🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/12/1999 | 23,00 | 23,31 | 22,00 | 23,00 | +0,27% | 5,71% | 68.200 |
| 30/12/1999 | 20,63 | 27,94 | 20,63 | 22,94 | +11,21% | 35,45% | 215.800 |
| 29/12/1999 | 20,00 | 21,00 | 19,63 | 20,63 | +3,77% | 6,88% | 192.800 |
| 28/12/1999 | 18,88 | 19,91 | 18,88 | 19,88 | +6,00% | 5,46% | 241.200 |
| 27/12/1999 | 18,16 | 18,88 | 18,13 | 18,75 | +3,45% | 4,13% | 106.600 |
| 23/12/1999 | 18,38 | 18,38 | 18,13 | 18,13 | -0,34% | 1,36% | 11.000 |
| 22/12/1999 | 17,81 | 18,19 | 17,69 | 18,19 | +2,11% | 2,81% | 142.400 |
| 21/12/1999 | 17,69 | 18,19 | 17,56 | 17,81 | +0,71% | 3,53% | 86.600 |
| 20/12/1999 | 17,57 | 17,69 | 17,56 | 17,69 | +0,18% | 0,71% | 158.800 |
| 17/12/1999 | 17,19 | 17,75 | 16,75 | 17,66 | +0,89% | 5,82% | 143.200 |
| 16/12/1999 | 17,38 | 17,56 | 16,63 | 17,50 | +0,00% | 5,40% | 56.000 |
| 15/12/1999 | 16,56 | 17,50 | 16,38 | 17,50 | +5,66% | 6,79% | 42.400 |
| 14/12/1999 | 16,56 | 17,63 | 16,50 | 16,56 | -6,36% | 6,79% | 30.600 |
| 13/12/1999 | 18,19 | 18,19 | 17,50 | 17,69 | -1,74% | 3,78% | 41.200 |
| 10/12/1999 | 18,06 | 18,25 | 18,00 | 18,00 | -1,03% | 1,38% | 15.000 |
| 09/12/1999 | 18,25 | 18,25 | 18,00 | 18,19 | +0,87% | 1,37% | 81.000 |
| 08/12/1999 | 18,50 | 18,50 | 18,00 | 18,03 | -0,52% | 2,70% | 108.600 |
| 07/12/1999 | 18,00 | 18,50 | 18,00 | 18,13 | +0,35% | 2,78% | 127.600 |
| 06/12/1999 | 18,06 | 18,50 | 18,00 | 18,06 | -1,03% | 2,77% | 200.600 |
| 03/12/1999 | 18,06 | 18,50 | 18,00 | 18,25 | +1,39% | 2,77% | 234.800 |
| 02/12/1999 | 18,38 | 18,38 | 18,00 | 18,00 | -0,35% | 2,04% | 148.000 |
| 01/12/1999 | 17,88 | 18,38 | 17,88 | 18,06 | -1,70% | 2,80% | 10.200 |
| 30/11/1999 | 18,31 | 18,38 | 17,88 | 18,38 | +2,80% | 2,73% | 55.800 |
| 29/11/1999 | 18,16 | 18,34 | 17,56 | 17,88 | -1,38% | 4,30% | 54.400 |
| 26/11/1999 | 18,16 | 18,16 | 17,91 | 18,13 | +0,00% | 1,38% | 44.200 |
| 24/11/1999 | 18,38 | 18,38 | 18,00 | 18,13 | -1,36% | 2,04% | 22.000 |
| 23/11/1999 | 18,47 | 18,69 | 18,38 | 18,38 | -0,68% | 1,69% | 42.200 |
| 22/11/1999 | 18,47 | 18,56 | 18,34 | 18,50 | -0,67% | 1,18% | 38.000 |
| 19/11/1999 | 18,47 | 18,69 | 18,06 | 18,63 | +0,85% | 3,38% | 61.600 |
| 18/11/1999 | 18,50 | 18,50 | 18,06 | 18,47 | +1,90% | 2,36% | 161.600 |